Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|April 1, 1990
[Viral myocarditis and classical virology. Clinico-virologic and experimental data]T Mertens, J P KruppenbacherDeutsche Zahnarztliche Zeitschrift|February 1, 1989
[Comparative test of the soluble toxicity of hydroxyapatite ceramics using human and animal osteoblasts]H Lang, J P Kruppenbacher, T MertensAntiviral Research|January 1, 1994
A rapid and reliable assay for testing acyclovir sensitivity of clinical herpes simplex virus isolates independent of virus dose and reading timeJ P Kruppenbacher, R Kläss, H J EggersInternational Journal of Legal Medicine|January 1, 1996
Interleukin-1 alpha (IL-1 alpha) and N-formyl-methionyl-leucyl-phenylalanine (FMLP) as potential inducers of supravital chemotaxisW Grellner, B Madea, J P Kruppenbacher, et al.The Journal of General Virology|April 1, 1985
Encephalomyocarditis virus and diabetes mellitus: studies on virus mutants in susceptible and non-susceptible miceJ P Kruppenbacher, T Mertens, H Müntefering, et al.Virology|September 1, 1994
The complete nucleotide sequence and construction of an infectious cDNA clone of a highly virulent encephalomyocarditis virusA Zimmermann, B Nelsen-Salz, J P Kruppenbacher, et al.Virchows Archiv. A, Pathological Anatomy and Histopathology|January 1, 1993
Outbred mice infected by an encephalomyocarditis virus variant: a model for studying chronic viral heart diseaseJ P Kruppenbacher, G Arnold, T Mertens, et al.The Journal of General Virology|December 1, 1993
HPLC is an effective and fast method for analysis of viral proteins: a study of encephalomyocarditis virus mutants differing in pathogenicityA Zimmermann, T Mertens, A Schulz, et al.Vox Sanguinis|January 1, 1990
Virological examinations of patients with AIDS-related complex/Walter-Reed 5 enrolled in a double-blind placebo-controlled study with intravenous gammaglobulin administration. Prognostic value of anti-p24 determination. The ARC-IVIG Study GroupT Mertens, A Ramon, J P Kruppenbacher, et al.Vaccine|April 1, 1996
Immunogenicity of an inactivated hepatitis A vaccine administered according to two different schedules and the interference of other "travellers" vaccines with the immune responseU Bienzle, H L Bock, J P Kruppenbacher, et al.Pageof 2